tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACAD Stock Latest News

ACADIA’s ACP-211 Trial Targets Difficult-to-Treat Depression: What Investors Should Watch
Company AnnouncementsACADIA’s ACP-211 Trial Targets Difficult-to-Treat Depression: What Investors Should Watch
5d ago
ACAD
Acadia Pharmaceuticals price target raised to $23 from $21 at Oppenheimer
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $23 from $21 at Oppenheimer
10d ago
ACAD
ACADIA Pharmaceuticals: U.S. Commercial Execution and Pipeline Optionality Drive Undervalued Buy Thesis Despite EU Trofinetide Delay
PremiumRatings
ACADIA Pharmaceuticals: U.S. Commercial Execution and Pipeline Optionality Drive Undervalued Buy Thesis Despite EU Trofinetide Delay
13d ago
ACAD
Acadia Pharmaceuticals price target lowered to $31 from $35 at RBC Capital
PremiumThe Fly
Acadia Pharmaceuticals price target lowered to $31 from $35 at RBC Capital
13d ago
ACAD
Closing Bell Movers: Palantir rallies 6% after Q4 beat
PremiumThe Fly
Closing Bell Movers: Palantir rallies 6% after Q4 beat
14d ago
FN
AES
Acadia Pharmaceuticals announces negative CHMP trend vole in Rett Syndrome
PremiumThe FlyAcadia Pharmaceuticals announces negative CHMP trend vole in Rett Syndrome
14d ago
ACAD
Acadia Pharmaceuticals price target raised to $31 from $27 at BofA
Premium
The Fly
Acadia Pharmaceuticals price target raised to $31 from $27 at BofA
17d ago
ACAD
Acadia Pharmaceuticals a solid opportunity here, says Canaccord
Premium
The Fly
Acadia Pharmaceuticals a solid opportunity here, says Canaccord
18d ago
ACAD
Acadia Pharmaceuticals a solid opportunity here, says Canaccord
PremiumThe Fly
Acadia Pharmaceuticals a solid opportunity here, says Canaccord
21d ago
ACAD
ACADIA Pharmaceuticals Clarifies Form 8-K Disclosure Treatment
PremiumCompany Announcements
ACADIA Pharmaceuticals Clarifies Form 8-K Disclosure Treatment
1M ago
8K
ACAD
Acadia Pharmaceuticals sees 2025 net sales to exceed $1B, consensus $1.08B
PremiumThe Fly
Acadia Pharmaceuticals sees 2025 net sales to exceed $1B, consensus $1.08B
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $40 from $35 at UBS
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $40 from $35 at UBS
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $36 from $33 at Citi
PremiumThe FlyAcadia Pharmaceuticals price target raised to $36 from $33 at Citi
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $34 from $29 at Needham
Premium
The Fly
Acadia Pharmaceuticals price target raised to $34 from $29 at Needham
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $37 from $32 at H.C. Wainwright
Premium
The Fly
Acadia Pharmaceuticals price target raised to $37 from $32 at H.C. Wainwright
2M ago
ACAD
Acadia Pharmaceuticals announces FDA approval of Daybue Stix for oral solution
PremiumThe Fly
Acadia Pharmaceuticals announces FDA approval of Daybue Stix for oral solution
2M ago
ACAD
Acadia Pharmaceuticals price target raised to $25 from $24 at Stifel
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $25 from $24 at Stifel
2M ago
ACAD
Acadia Pharmaceuticals price target raised to $29 from $24 at Mizuho
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $29 from $24 at Mizuho
3M ago
ACAD
Acadia Pharmaceuticals price target lowered to $31 from $33 at JPMorgan
PremiumThe Fly
Acadia Pharmaceuticals price target lowered to $31 from $33 at JPMorgan
3M ago
ACAD
ACADIA Pharmaceuticals: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
PremiumRatingsACADIA Pharmaceuticals: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
3M ago
ACAD
ACADIA Pharmaceuticals Q3 2025 Earnings Call Highlights
Premium
Company Announcements
ACADIA Pharmaceuticals Q3 2025 Earnings Call Highlights
3M ago
ACAD
ACADIA Pharmaceuticals: Strong Growth Prospects and Strategic Positioning Justify Buy Rating
Premium
Ratings
ACADIA Pharmaceuticals: Strong Growth Prospects and Strategic Positioning Justify Buy Rating
3M ago
ACAD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >